| | Class 2 Device Recall BridgeAssurant |  |
| Date Initiated by Firm | February 27, 2003 |
| Date Posted | May 07, 2003 |
| Recall Status1 |
Terminated 3 on September 22, 2003 |
| Recall Number | Z-0789-03 |
| Recall Event ID |
25794 |
| Product Classification |
Stents, Drains And Dilators For The Biliary Ducts - Product Code FGE
|
| Product | Medtronic AVE brand BridgeAssurant Balloon Expandable Stent Delivery System
for Biliary Catheter;Model #s:
FB720VF, FB730 VF, FB740 VF, FB760 VF, FB820VF, FB830VF, FB840VF, FB860VF;
FB720VL, FB730VL, FB820VL, FB830VL;
FB720F, FB730F, FB740F, FB760F, FB820F, FB830F, FB840F, FB860F;
FB720L, FB730L, FB820L, FB830L |
| Code Information |
Specific lots of 7 and 8 mm in diameter: 2E16E06, 2F05E10, 2F11E12, 2E15E01, 2F20E13, 2H06E02, V432C25E12, V432D04E14, 2D16E09, 2D29E08, 2E06E09, 2E28E15, 2G11E01, 2G10E01, 2H01E07, 2H15E06, 2K17E02, 2E21E01, 2H29E08, 2K24E02, V432D1E12, 2D12E12, 2D17E13, 2E10E13, 2E22E20, 2E24E10, 2E30E01, 2G15E01, 2G26E01, 2G24E10, 2K03E01, 2K17E01, 2L11E09, 2D30E02, 2E13E14, 2E21E14, 2E28E16, 2H19E18, 2L13E01, 2E07E13, 2E18E01, 2K23E02, 2E21E12, 2H06E03, V432C23E01, V432C29E11, 2D08E14, V432D05E12, 2D25E10, 2E16E16, 2G18E02, 2G26E23, 2H09E08, 2H14E05, 2K11E14, 2L07E06, 2E24E01, 2G24E11, 2H28E22, 2L08E04, V432C28E12, V432D02E09, 2D15E24, 2D24E13, 2E01E10, 2D18E12, 2E1415, 2E21E15, 2F24E13, 2G11E11, 2G17E01, 2G22E13, 2G26E01, 2H16E09, 2K15E03, 2K21E06, 2K21E05, 2L13E02, 2D24E12, 2D26E09, 2E15E25, 2F04E12, 2F18E13, 2H15E05, 2H21E10, 2J03E11, 2K03E07 |
| FEI Number |
3001452571
|
Recalling Firm/ Manufacturer |
Medtronic Ave Inc 3576 Unocal Place Santa Rosa CA 95403
|
| For Additional Information Contact | Debby Hinman 707-591-2234 |
Manufacturer Reason for Recall | During use, device may exhibit high insertional resistance which may result in device damage, kinking and subsequent balloon deflation difficulties. |
FDA Determined Cause 2 | Other |
| Action | A letter was sent to each US commercial accounts via UPS overnight mailing on Saturday, March 1st, 2003 for delivery on Monday, March 3rd 2003. The notification instructs firm''s customers to sequester product from the specific lot numbers so that firm''s rep could assist in removing the affected product. |
| Distribution | Product was released for distribution to 446 consignees nationwide. The recall was appropriately extended to the user level; i.e., Clinics, hospitals and medical Centers who received the recalled product. There were no shipments to U.S. Government facilities or foreign or Canadian distribution. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|